Table 2 The major outcomes of the included patients
Variables | Value |
|---|---|
In-hospital mortality, n (%) | 82 (30.3%) |
Cause of death | |
 Multiple organ failure, n (%) | 40 (48.8%) |
 Heart failure, n (%) | 35 (42.7%) |
 Hemorrhagic shock, n (%) | 2 (2.4%) |
 Sepsis, n (%) | 5 (6.1%) |
 Reoperation, n (%) | 17 (6.3%) |
 AKI, n (%) | 222 (81.9%) |
 Stage of AKI | |
  Stage 1, n (%) | 102 (40.2%) |
  Stage 2, n (%) | 34 (12.5%) |
  Stage 3, n (%) | 84 (29.2%) |
 Use of CRRT, n (%) | 50 (18.5%) |
 Use of PE/BA, n (%) | 11 (14.1%) |
 Use of IABP, n (%) | 1 (0.4%) |
 Use of ECMO, n (%) | 7 (2.6%) |
 Use of vasoactive agent, n (%) | 173 (63.8%) |
 Mechanical ventilation time, mean ± SD (days) | 3.3 ± 5.7 |
 The amount of blood transfusion, mean ± SD (U) | 34.8 ± 43.3 |
 In hospital time, mean ± SD (days) | 19.8 ± 10.7 |
 ICU stay time, mean ± SD (days) | 6.6 ± 6.3 |
 Onset of severe hyperbilirubinemia, mean ± SD (days) | 2.8 ± 1.3 |